ArticleEJHaem2020
Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL.
Rohitashva Agrawal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleEJHaem2020
Rohitashva Agrawal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.